Lopinavir and Ritonavir Oral Solution — FDA Drug Shortage

To Be Discontinued — AbbVie Inc.

The FDA lists a drug shortage record for Lopinavir and Ritonavir Oral Solution (oral solution) from AbbVie Inc. with status To Be Discontinued. The shortage was first posted on Jul 24, 2026.

Shortage details

Status
To Be Discontinued
Company
AbbVie Inc.
Package NDC
0074-3956-46
Dosage Form
Oral Solution
Presentation
Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46)
Initial Posting
Jul 24, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.